Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Small Molecule Targeted Anti-cancer Drug Market Size Analysis from 2022 to 2027

1.5.1 Global Small Molecule Targeted Anti-cancer Drug Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Small Molecule Targeted Anti-cancer Drug Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Small Molecule Targeted Anti-cancer Drug Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Small Molecule Targeted Anti-cancer Drug Industry Impact

Chapter 2 Global Small Molecule Targeted Anti-cancer Drug Competition by Types, Applications, and Top Regions and Countries

2.1 Global Small Molecule Targeted Anti-cancer Drug (Volume and Value) by Type

2.1.1 Global Small Molecule Targeted Anti-cancer Drug Consumption and Market Share by Type (2016-2021)

2.1.2 Global Small Molecule Targeted Anti-cancer Drug Revenue and Market Share by Type (2016-2021)

2.2 Global Small Molecule Targeted Anti-cancer Drug (Volume and Value) by Application

2.2.1 Global Small Molecule Targeted Anti-cancer Drug Consumption and Market Share by Application (2016-2021)

2.2.2 Global Small Molecule Targeted Anti-cancer Drug Revenue and Market Share by Application (2016-2021)

2.3 Global Small Molecule Targeted Anti-cancer Drug (Volume and Value) by Regions

2.3.1 Global Small Molecule Targeted Anti-cancer Drug Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Small Molecule Targeted Anti-cancer Drug Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Small Molecule Targeted Anti-cancer Drug Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Small Molecule Targeted Anti-cancer Drug Consumption by Regions (2016-2021)

4.2 North America Small Molecule Targeted Anti-cancer Drug Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Small Molecule Targeted Anti-cancer Drug Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Small Molecule Targeted Anti-cancer Drug Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Small Molecule Targeted Anti-cancer Drug Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Small Molecule Targeted Anti-cancer Drug Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Small Molecule Targeted Anti-cancer Drug Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Small Molecule Targeted Anti-cancer Drug Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Small Molecule Targeted Anti-cancer Drug Sales, Consumption, Export, Import (2016-2021)

4.10 South America Small Molecule Targeted Anti-cancer Drug Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Small Molecule Targeted Anti-cancer Drug Market Analysis

5.1 North America Small Molecule Targeted Anti-cancer Drug Consumption and Value Analysis

5.1.1 North America Small Molecule Targeted Anti-cancer Drug Market Under COVID-19

5.2 North America Small Molecule Targeted Anti-cancer Drug Consumption Volume by Types

5.3 North America Small Molecule Targeted Anti-cancer Drug Consumption Structure by Application

5.4 North America Small Molecule Targeted Anti-cancer Drug Consumption by Top Countries

5.4.1 United States Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

5.4.2 Canada Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

5.4.3 Mexico Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

Chapter 6 East Asia Small Molecule Targeted Anti-cancer Drug Market Analysis

6.1 East Asia Small Molecule Targeted Anti-cancer Drug Consumption and Value Analysis

6.1.1 East Asia Small Molecule Targeted Anti-cancer Drug Market Under COVID-19

6.2 East Asia Small Molecule Targeted Anti-cancer Drug Consumption Volume by Types

6.3 East Asia Small Molecule Targeted Anti-cancer Drug Consumption Structure by Application

6.4 East Asia Small Molecule Targeted Anti-cancer Drug Consumption by Top Countries

6.4.1 China Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

6.4.2 Japan Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

6.4.3 South Korea Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

Chapter 7 Europe Small Molecule Targeted Anti-cancer Drug Market Analysis

7.1 Europe Small Molecule Targeted Anti-cancer Drug Consumption and Value Analysis

7.1.1 Europe Small Molecule Targeted Anti-cancer Drug Market Under COVID-19

7.2 Europe Small Molecule Targeted Anti-cancer Drug Consumption Volume by Types

7.3 Europe Small Molecule Targeted Anti-cancer Drug Consumption Structure by Application

7.4 Europe Small Molecule Targeted Anti-cancer Drug Consumption by Top Countries

7.4.1 Germany Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

7.4.2 UK Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

7.4.3 France Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

7.4.4 Italy Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

7.4.5 Russia Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

7.4.6 Spain Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

7.4.7 Netherlands Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

7.4.8 Switzerland Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

7.4.9 Poland Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

Chapter 8 South Asia Small Molecule Targeted Anti-cancer Drug Market Analysis

8.1 South Asia Small Molecule Targeted Anti-cancer Drug Consumption and Value Analysis

8.1.1 South Asia Small Molecule Targeted Anti-cancer Drug Market Under COVID-19

8.2 South Asia Small Molecule Targeted Anti-cancer Drug Consumption Volume by Types

8.3 South Asia Small Molecule Targeted Anti-cancer Drug Consumption Structure by Application

8.4 South Asia Small Molecule Targeted Anti-cancer Drug Consumption by Top Countries

8.4.1 India Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

8.4.2 Pakistan Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Analysis

9.1 Southeast Asia Small Molecule Targeted Anti-cancer Drug Consumption and Value Analysis

9.1.1 Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Under COVID-19

9.2 Southeast Asia Small Molecule Targeted Anti-cancer Drug Consumption Volume by Types

9.3 Southeast Asia Small Molecule Targeted Anti-cancer Drug Consumption Structure by Application

9.4 Southeast Asia Small Molecule Targeted Anti-cancer Drug Consumption by Top Countries

9.4.1 Indonesia Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

9.4.2 Thailand Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

9.4.3 Singapore Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

9.4.4 Malaysia Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

9.4.5 Philippines Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

9.4.6 Vietnam Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

9.4.7 Myanmar Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

Chapter 10 Middle East Small Molecule Targeted Anti-cancer Drug Market Analysis

10.1 Middle East Small Molecule Targeted Anti-cancer Drug Consumption and Value Analysis

10.1.1 Middle East Small Molecule Targeted Anti-cancer Drug Market Under COVID-19

10.2 Middle East Small Molecule Targeted Anti-cancer Drug Consumption Volume by Types

10.3 Middle East Small Molecule Targeted Anti-cancer Drug Consumption Structure by Application

10.4 Middle East Small Molecule Targeted Anti-cancer Drug Consumption by Top Countries

10.4.1 Turkey Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

10.4.3 Iran Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

10.4.5 Israel Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

10.4.6 Iraq Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

10.4.7 Qatar Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

10.4.8 Kuwait Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

10.4.9 Oman Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

Chapter 11 Africa Small Molecule Targeted Anti-cancer Drug Market Analysis

11.1 Africa Small Molecule Targeted Anti-cancer Drug Consumption and Value Analysis

11.1.1 Africa Small Molecule Targeted Anti-cancer Drug Market Under COVID-19

11.2 Africa Small Molecule Targeted Anti-cancer Drug Consumption Volume by Types

11.3 Africa Small Molecule Targeted Anti-cancer Drug Consumption Structure by Application

11.4 Africa Small Molecule Targeted Anti-cancer Drug Consumption by Top Countries

11.4.1 Nigeria Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

11.4.2 South Africa Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

11.4.3 Egypt Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

11.4.4 Algeria Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

11.4.5 Morocco Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

Chapter 12 Oceania Small Molecule Targeted Anti-cancer Drug Market Analysis

12.1 Oceania Small Molecule Targeted Anti-cancer Drug Consumption and Value Analysis

12.2 Oceania Small Molecule Targeted Anti-cancer Drug Consumption Volume by Types

12.3 Oceania Small Molecule Targeted Anti-cancer Drug Consumption Structure by Application

12.4 Oceania Small Molecule Targeted Anti-cancer Drug Consumption by Top Countries

12.4.1 Australia Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

12.4.2 New Zealand Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

Chapter 13 South America Small Molecule Targeted Anti-cancer Drug Market Analysis

13.1 South America Small Molecule Targeted Anti-cancer Drug Consumption and Value Analysis

13.1.1 South America Small Molecule Targeted Anti-cancer Drug Market Under COVID-19

13.2 South America Small Molecule Targeted Anti-cancer Drug Consumption Volume by Types

13.3 South America Small Molecule Targeted Anti-cancer Drug Consumption Structure by Application

13.4 South America Small Molecule Targeted Anti-cancer Drug Consumption Volume by Major Countries

13.4.1 Brazil Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

13.4.2 Argentina Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

13.4.3 Columbia Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

13.4.4 Chile Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

13.4.5 Venezuela Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

13.4.6 Peru Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

13.4.8 Ecuador Small Molecule Targeted Anti-cancer Drug Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Small Molecule Targeted Anti-cancer Drug Business

14.1 Astrazeneca

14.1.1 Astrazeneca Company Profile

14.1.2 Astrazeneca Small Molecule Targeted Anti-cancer Drug Product Specification

14.1.3 Astrazeneca Small Molecule Targeted Anti-cancer Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Eisai

14.2.1 Eisai Company Profile

14.2.2 Eisai Small Molecule Targeted Anti-cancer Drug Product Specification

14.2.3 Eisai Small Molecule Targeted Anti-cancer Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Bayer

14.3.1 Bayer Company Profile

14.3.2 Bayer Small Molecule Targeted Anti-cancer Drug Product Specification

14.3.3 Bayer Small Molecule Targeted Anti-cancer Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Novartis

14.4.1 Novartis Company Profile

14.4.2 Novartis Small Molecule Targeted Anti-cancer Drug Product Specification

14.4.3 Novartis Small Molecule Targeted Anti-cancer Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Boehringer-Ingelheim

14.5.1 Boehringer-Ingelheim Company Profile

14.5.2 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Product Specification

14.5.3 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Millennium Pharmaceuticals

14.6.1 Millennium Pharmaceuticals Company Profile

14.6.2 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Product Specification

14.6.3 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Bristol-Myers Squibb

14.7.1 Bristol-Myers Squibb Company Profile

14.7.2 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Product Specification

14.7.3 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Abbvie

14.8.1 Abbvie Company Profile

14.8.2 Abbvie Small Molecule Targeted Anti-cancer Drug Product Specification

14.8.3 Abbvie Small Molecule Targeted Anti-cancer Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Exelixis

14.9.1 Exelixis Company Profile

14.9.2 Exelixis Small Molecule Targeted Anti-cancer Drug Product Specification

14.9.3 Exelixis Small Molecule Targeted Anti-cancer Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Pfizer

14.10.1 Pfizer Company Profile

14.10.2 Pfizer Small Molecule Targeted Anti-cancer Drug Product Specification

14.10.3 Pfizer Small Molecule Targeted Anti-cancer Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Roche

14.11.1 Roche Company Profile

14.11.2 Roche Small Molecule Targeted Anti-cancer Drug Product Specification

14.11.3 Roche Small Molecule Targeted Anti-cancer Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 Bettapharma

14.12.1 Bettapharma Company Profile

14.12.2 Bettapharma Small Molecule Targeted Anti-cancer Drug Product Specification

14.12.3 Bettapharma Small Molecule Targeted Anti-cancer Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Small Molecule Targeted Anti-cancer Drug Market Forecast (2022-2027)

15.1 Global Small Molecule Targeted Anti-cancer Drug Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Small Molecule Targeted Anti-cancer Drug Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Small Molecule Targeted Anti-cancer Drug Value and Growth Rate Forecast (2022-2027)

15.2 Global Small Molecule Targeted Anti-cancer Drug Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Small Molecule Targeted Anti-cancer Drug Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Small Molecule Targeted Anti-cancer Drug Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Small Molecule Targeted Anti-cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Small Molecule Targeted Anti-cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Small Molecule Targeted Anti-cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Small Molecule Targeted Anti-cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Small Molecule Targeted Anti-cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Small Molecule Targeted Anti-cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Small Molecule Targeted Anti-cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Small Molecule Targeted Anti-cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Small Molecule Targeted Anti-cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Small Molecule Targeted Anti-cancer Drug Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Small Molecule Targeted Anti-cancer Drug Consumption Forecast by Type (2022-2027)

15.3.2 Global Small Molecule Targeted Anti-cancer Drug Revenue Forecast by Type (2022-2027)

15.3.3 Global Small Molecule Targeted Anti-cancer Drug Price Forecast by Type (2022-2027)

15.4 Global Small Molecule Targeted Anti-cancer Drug Consumption Volume Forecast by Application (2022-2027)

15.5 Small Molecule Targeted Anti-cancer Drug Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology